HIV/AIDS News

I initially became hooked on ID when I was a medical student rounding on ID service and was evaluating a person with pneumonia who had just expectorated purulent sputum.

A notable proportion of health care providers plan to reduce or stop providing HIV care over the next half decade, even as the need for such care is expected to rise, results from a quantitative national survey showed.

As a physician trained in India, I saw the devastating impact of infectious diseases like TB, malaria and waterborne illnesses, and the profound difference public health interventions can have. That led to my career in global health.

LOS ANGELES —In this video from IDWeek, Vani Vannappagari, MBBS, PhD, MPH, global head of epidemiology and real-world evidence at ViiV Healthcare, discusses study findings demonstrating the effectiveness of cabotegravir for HIV prevention.

Less than 3% of patients tested for a bacterial STI in nearly a dozen EDs were also tested for HIV, demonstrating widespread nonadherence to a CDC recommendation, according to a study presented at IDWeek.

LOS ANGELES — Lenacapavir, the twice-yearly injectable HIV drug, could potentially transform HIV prevention if it is approved as PrEP, research has shown.

Access to pre-exposure prophylaxis remains insufficient, especially among Black, Hispanic and Medicare-insured populations, results of an analysis presented at IDWeek suggested.

A significant number of Medicaid-insured infants infected with HIV in the first year of their life did not receive postnatal antiretroviral prophylaxis, a study presented at IDWeek showed.

LOS ANGELES — Healio is on-site again for IDWeek, which is being held at the Los Angeles Convention Center from Oct. 16-19.